Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Hydroxylamine Derivatives as a New Paradigm in the Search of Antibacterial Agents.

Miret-Casals L, Baelo A, Julián E, Astola J, Lobo-Ruiz A, Albericio F, Torrents E.

ACS Omega. 2018 Dec 11;3(12):17057-17069. doi: 10.1021/acsomega.8b01384. eCollection 2018 Dec 31.

2.

Novel Oleanolic and Maslinic Acid Derivatives as a Promising Treatment against Bacterial Biofilm in Nosocomial Infections: An in Vitro and in Vivo Study.

Blanco-Cabra N, Vega-Granados K, Moya-Andérico L, Vukomanovic M, Parra A, Álvarez de Cienfuegos L, Torrents E.

ACS Infect Dis. 2019 Sep 13;5(9):1581-1589. doi: 10.1021/acsinfecdis.9b00125. Epub 2019 Jul 16.

PMID:
31268675
3.

Trends in the incidence and mortality of patients with community-acquired septic shock 2003-2016.

Valles J, Fontanals D, Oliva JC, Martínez M, Navas A, Mesquida J, Gruartmoner G, de Haro C, Mestre J, Guía C, Rodriguez A, Torrents E, Espinal C, Ochagavía A, Diaz E.

J Crit Care. 2019 Oct;53:46-52. doi: 10.1016/j.jcrc.2019.05.025. Epub 2019 Jun 4.

PMID:
31195155
4.

High time resolution and high signal-to-noise monitoring of the bacterial growth kinetics in the presence of plasmonic nanoparticles.

Vukomanovic M, Torrents E.

J Nanobiotechnology. 2019 Feb 1;17(1):21. doi: 10.1186/s12951-019-0459-1.

5.

New Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action.

Ohui K, Afanasenko E, Bacher F, Ting RLX, Zafar A, Blanco-Cabra N, Torrents E, Dömötör O, May NV, Darvasiova D, Enyedy ÉA, Popović-Bijelić A, Reynisson J, Rapta P, Babak MV, Pastorin G, Arion VB.

J Med Chem. 2019 Jan 24;62(2):512-530. doi: 10.1021/acs.jmedchem.8b01031. Epub 2018 Dec 18.

6.

Pentafluorosulfanyl-containing Triclocarban Analogs with Potent Antimicrobial Activity.

Pujol E, Blanco-Cabra N, Julián E, Leiva R, Torrents E, Vázquez S.

Molecules. 2018 Nov 2;23(11). pii: E2853. doi: 10.3390/molecules23112853.

7.

Dielectric constant of flagellin proteins measured by scanning dielectric microscopy.

Lozano H, Fabregas R, Blanco-Cabra N, Millán-Solsona R, Torrents E, Fumagalli L, Gomila G.

Nanoscale. 2018 Oct 18;10(40):19188-19194. doi: 10.1039/c8nr06190d.

PMID:
30302472
8.

Aerobic Vitamin B12 Biosynthesis Is Essential for Pseudomonas aeruginosa Class II Ribonucleotide Reductase Activity During Planktonic and Biofilm Growth.

Crespo A, Blanco-Cabra N, Torrents E.

Front Microbiol. 2018 May 15;9:986. doi: 10.3389/fmicb.2018.00986. eCollection 2018.

9.

Regulation of ribonucleotide synthesis by the Pseudomonas aeruginosa two-component system AlgR in response to oxidative stress.

Crespo A, Pedraz L, Van Der Hofstadt M, Gomila G, Torrents E.

Sci Rep. 2017 Dec 20;7(1):17892. doi: 10.1038/s41598-017-17917-7.

10.

High-Dose Daptomycin Is Effective as an Antibiotic Lock Therapy in a Rabbit Model of Staphylococcus epidermidis Catheter-Related Infection.

Basas J, Palau M, Ratia C, Del Pozo JL, Martín-Gómez MT, Gomis X, Torrents E, Almirante B, Gavaldà J.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01777-17. doi: 10.1128/AAC.01777-17. Print 2018 Feb.

11.

A single point mutation in class III ribonucleotide reductase promoter renders Pseudomonas aeruginosa PAO1 inefficient for anaerobic growth and infection.

Crespo A, Gavaldà J, Julián E, Torrents E.

Sci Rep. 2017 Oct 17;7(1):13350. doi: 10.1038/s41598-017-14051-2.

12.

Erratum to: Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons.

Urrea L, Segura-Feliu M, Masuda-Suzukake M, Hervera A, Pedraz L, García-Aznar JM, Vila M, Samitier J, Torrents E, Ferrer I, Gavín R, Hagesawa M, Del Río JA.

Mol Neurobiol. 2018 Mar;55(3):1861. doi: 10.1007/s12035-017-0553-z. No abstract available.

PMID:
28477141
13.

Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons.

Urrea L, Segura-Feliu M, Masuda-Suzukake M, Hervera A, Pedraz L, García-Aznar JM, Vila M, Samitier J, Torrents E, Ferrer I, Gavín R, Hagesawa M, Del Río JA.

Mol Neurobiol. 2018 Mar;55(3):1847-1860. doi: 10.1007/s12035-017-0451-4. Epub 2017 Feb 22. Erratum in: Mol Neurobiol. 2017 May 5;:.

14.

Impact of Source Control in Patients With Severe Sepsis and Septic Shock.

Martínez ML, Ferrer R, Torrents E, Guillamat-Prats R, Gomà G, Suárez D, Álvarez-Rocha L, Pozo Laderas JC, Martín-Loeches I, Levy MM, Artigas A; Edusepsis Study Group.

Crit Care Med. 2017 Jan;45(1):11-19.

PMID:
27611975
15.

Toward a personalized response approach in sepsis 4.0.

de Haro C, Torrents E, Ferrer R, Artigas A, Rodriguez A, Martin-Loeches I.

Med Intensiva. 2017 Jan - Feb;41(1):55-56. doi: 10.1016/j.medin.2016.06.005. Epub 2016 Sep 5. English, Spanish. No abstract available.

16.

Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique.

Basas J, Morer A, Ratia C, Martín MT, Del Pozo JL, Gomis X, Rojo-Molinero E, Torrents E, Almirante B, Gavaldà J.

J Antimicrob Chemother. 2016 Oct;71(10):2895-901. doi: 10.1093/jac/dkw251. Epub 2016 Jul 4.

PMID:
27378814
17.

Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment.

Noguera-Ortega E, Blanco-Cabra N, Rabanal RM, Sánchez-Chardi A, Roldán M, Guallar-Garrido S, Torrents E, Luquin M, Julián E.

Sci Rep. 2016 Jun 6;6:27232. doi: 10.1038/srep27232.

18.

Pseudomonas aeruginosa Exhibits Deficient Biofilm Formation in the Absence of Class II and III Ribonucleotide Reductases Due to Hindered Anaerobic Growth.

Crespo A, Pedraz L, Astola J, Torrents E.

Front Microbiol. 2016 May 9;7:688. doi: 10.3389/fmicb.2016.00688. eCollection 2016.

19.

Draft Genome Sequence of Mycobacterium brumae ATCC 51384.

D'Auria G, Torrents E, Luquin M, Comas I, Julián E.

Genome Announc. 2016 Apr 28;4(2). pii: e00237-16. doi: 10.1128/genomeA.00237-16.

20.

Nonpathogenic Mycobacterium brumae Inhibits Bladder Cancer Growth In Vitro, Ex Vivo, and In Vivo.

Noguera-Ortega E, Secanella-Fandos S, Eraña H, Gasión J, Rabanal RM, Luquin M, Torrents E, Julián E.

Eur Urol Focus. 2016 Apr;2(1):67-76. doi: 10.1016/j.euf.2015.03.003. Epub 2015 Jun 6.

PMID:
28723453
21.

Correction for Dreux et al., Ribonucleotide Reductase Repressor NrdR as a Novel Regulator for Motility and Chemotaxis during Adherent-Invasive Escherichia coli Infection.

Dreux N, Cendra Mdel M, Massier S, Darfeuille-Michaud A, Barnich N, Torrents E.

Infect Immun. 2015 Oct;83(10):4174. doi: 10.1128/IAI.00728-15. No abstract available.

22.

γ Irradiated Mycobacteria Enhance Survival in Bladder Tumor Bearing Mice Although Less Efficaciously than Live Mycobacteria.

Noguera-Ortega E, Rabanal RM, Secanella-Fandos S, Torrents E, Luquin M, Julián E.

J Urol. 2016 Jan;195(1):198-205. doi: 10.1016/j.juro.2015.07.011. Epub 2015 Jul 10.

PMID:
26165584
23.

Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.

Baelo A, Levato R, Julián E, Crespo A, Astola J, Gavaldà J, Engel E, Mateos-Timoneda MA, Torrents E.

J Control Release. 2015 Jul 10;209:150-8. doi: 10.1016/j.jconrel.2015.04.028. Epub 2015 Apr 23.

PMID:
25913364
24.

Function of the Pseudomonas aeruginosa NrdR Transcription Factor: Global Transcriptomic Analysis and Its Role on Ribonucleotide Reductase Gene Expression.

Crespo A, Pedraz L, Torrents E.

PLoS One. 2015 Apr 24;10(4):e0123571. doi: 10.1371/journal.pone.0123571. eCollection 2015.

25.
26.

Dielectrophoresis chips improve PCR detection of the food-spoiling yeast Zygosaccharomyces rouxii in apple juice.

del Carmen Jaramillo M, Huttener M, Alvarez JM, Homs-Corbera A, Samitier J, Torrents E, Juárez A.

Electrophoresis. 2015 Jul;36(13):1471-8. doi: 10.1002/elps.201400483. Epub 2015 May 12.

PMID:
25808673
27.

Methyl-hydroxylamine as an efficacious antibacterial agent that targets the ribonucleotide reductase enzyme.

Julián E, Baelo A, Gavaldà J, Torrents E.

PLoS One. 2015 Mar 17;10(3):e0122049. doi: 10.1371/journal.pone.0122049. eCollection 2015.

28.

Ribonucleotide reductase NrdR as a novel regulator for motility and chemotaxis during adherent-invasive Escherichia coli infection.

Dreux N, del Mar Cendra M, Massier S, Darfeuille-Michaud A, Barnich N, Torrents E.

Infect Immun. 2015 Apr;83(4):1305-17. doi: 10.1128/IAI.02772-14. Epub 2015 Jan 20. Erratum in: Infect Immun. 2015 Oct;83(10):4174.

29.

Antibacterial activity of novel benzopolycyclic amines.

Barniol-Xicota M, Escandell A, Valverde E, Julián E, Torrents E, Vázquez S.

Bioorg Med Chem. 2015 Jan 15;23(2):290-6. doi: 10.1016/j.bmc.2014.11.041. Epub 2014 Dec 3.

PMID:
25515953
30.

Label-free ITO-based immunosensor for the detection of very low concentrations of pathogenic bacteria.

Barreiros dos Santos M, Azevedo S, Agusil JP, Prieto-Simón B, Sporer C, Torrents E, Juárez A, Teixeira V, Samitier J.

Bioelectrochemistry. 2015 Feb;101:146-52.

PMID:
25460610
31.

Highly cytotoxic DNA-interacting copper(II) coordination compounds.

Brissos RF, Torrents E, dos Santos Mello FM, Carvalho Pires W, Silveira-Lacerda Ede P, Caballero AB, Caubet A, Massera C, Roubeau O, Teat SJ, Gamez P.

Metallomics. 2014 Oct;6(10):1853-68. doi: 10.1039/c4mt00152d. Epub 2014 Aug 6.

PMID:
25096758
32.

Ribonucleotide reductases: essential enzymes for bacterial life.

Torrents E.

Front Cell Infect Microbiol. 2014 Apr 28;4:52. doi: 10.3389/fcimb.2014.00052. eCollection 2014. Review.

33.

H-NS is a novel transcriptional modulator of the ribonucleotide reductase genes in Escherichia coli.

Cendra Mdel M, Juárez A, Madrid C, Torrents E.

J Bacteriol. 2013 Sep;195(18):4255-63. doi: 10.1128/JB.00490-13. Epub 2013 Jul 19.

34.

Acute respiratory distress syndrome: prevention and early recognition.

de Haro C, Martin-Loeches I, Torrents E, Artigas A.

Ann Intensive Care. 2013 Apr 24;3(1):11. doi: 10.1186/2110-5820-3-11.

35.

Increasing PCR sensitivity by removal of polymerase inhibitors in environmental samples by using dielectrophoresis.

Jaramillo Mdel C, Martínez-Duarte R, Hüttener M, Renaud P, Torrents E, Juárez A.

Biosens Bioelectron. 2013 May 15;43:297-303. doi: 10.1016/j.bios.2012.12.049. Epub 2013 Jan 2.

PMID:
23337260
36.

Biofilm modifies expression of ribonucleotide reductase genes in Escherichia coli.

Cendra Mdel M, Juárez A, Torrents E.

PLoS One. 2012;7(9):e46350. doi: 10.1371/journal.pone.0046350. Epub 2012 Sep 26.

37.

Quartz tuning fork studies on the surface properties of Pseudomonas aeruginosa during early stages of biofilm formation.

Otero J, Baños R, González L, Torrents E, Juárez A, Puig-Vidal M.

Colloids Surf B Biointerfaces. 2013 Feb 1;102:117-23. doi: 10.1016/j.colsurfb.2012.08.013. Epub 2012 Aug 19.

PMID:
23018019
38.

Dual role of Cu²⁺ ions on the aggregation and degradation of soluble Aβ oligomers and protofibrils investigated by fluorescence spectroscopy and AFM.

García S, Cuscó C, Brissos RF, Torrents E, Caubet A, Gamez P.

J Inorg Biochem. 2012 Nov;116:26-36. doi: 10.1016/j.jinorgbio.2012.07.007. Epub 2012 Jul 16.

PMID:
23010326
39.

NrdH-redoxin protein mediates high enzyme activity in manganese-reconstituted ribonucleotide reductase from Bacillus anthracis.

Crona M, Torrents E, Røhr AK, Hofer A, Furrer E, Tomter AB, Andersson KK, Sahlin M, Sjöberg BM.

J Biol Chem. 2011 Sep 23;286(38):33053-60. doi: 10.1074/jbc.M111.278119. Epub 2011 Aug 6.

40.

Shift in ribonucleotide reductase gene expression in Pseudomonas aeruginosa during infection.

Sjöberg BM, Torrents E.

Infect Immun. 2011 Jul;79(7):2663-9. doi: 10.1128/IAI.01212-10. Epub 2011 Apr 18.

41.

Ribonucleotide reduction - horizontal transfer of a required function spans all three domains.

Lundin D, Gribaldo S, Torrents E, Sjöberg BM, Poole AM.

BMC Evol Biol. 2010 Dec 10;10:383. doi: 10.1186/1471-2148-10-383.

42.

High-resolution crystal structures of the flavoprotein NrdI in oxidized and reduced states--an unusual flavodoxin. Structural biology.

Johansson R, Torrents E, Lundin D, Sprenger J, Sahlin M, Sjöberg BM, Logan DT.

FEBS J. 2010 Oct;277(20):4265-77. doi: 10.1111/j.1742-4658.2010.07815.x. Epub 2010 Sep 10.

43.

On-line separation of bacterial cells by carbon-electrode dielectrophoresis.

Jaramillo Mdel C, Torrents E, Martínez-Duarte R, Madou MJ, Juárez A.

Electrophoresis. 2010 Sep;31(17):2921-8. doi: 10.1002/elps.201000082.

PMID:
20690146
44.

Prevalence and concentration of non-tuberculous mycobacteria in cooling towers by means of quantitative PCR: a prospective study.

Adrados B, Julián E, Codony F, Torrents E, Luquin M, Morató J.

Curr Microbiol. 2011 Jan;62(1):313-9. doi: 10.1007/s00284-010-9706-2. Epub 2010 Jul 18.

PMID:
20640853
45.

Subunit and small-molecule interaction of ribonucleotide reductases via surface plasmon resonance biosensor analyses.

Crona M, Furrer E, Torrents E, Edgell DR, Sjöberg BM.

Protein Eng Des Sel. 2010 Aug;23(8):633-41. doi: 10.1093/protein/gzq035. Epub 2010 Jun 9.

46.

Antibacterial activity of radical scavengers against class Ib ribonucleotide reductase from Bacillus anthracis.

Torrents E, Sjöberg BM.

Biol Chem. 2010 Feb-Mar;391(2-3):229-34. doi: 10.1515/BC.2010.017.

PMID:
20030587
47.
48.

Fumarate and nitrate reduction (FNR) dependent activation of the Escherichia coli anaerobic ribonucleotide reductase nrdDG promoter.

Roca I, Ballana E, Panosa A, Torrents E, Gibert I.

Int Microbiol. 2008 Mar;11(1):49-56.

PMID:
18683632
49.

NrdI essentiality for class Ib ribonucleotide reduction in Streptococcus pyogenes.

Roca I, Torrents E, Sahlin M, Gibert I, Sjöberg BM.

J Bacteriol. 2008 Jul;190(14):4849-58. doi: 10.1128/JB.00185-08. Epub 2008 May 23.

50.

A functional homing endonuclease in the Bacillus anthracis nrdE group I intron.

Nord D, Torrents E, Sjöberg BM.

J Bacteriol. 2007 Jul;189(14):5293-301. Epub 2007 May 11.

Supplemental Content

Loading ...
Support Center